Immunotherapy Improves Advanced Esophageal Squamous-Cell Carcinoma Survival Across Most Smoking Groups
A meta-analysis of eight randomized trials found that immune checkpoint inhibitors significantly improved overall survival in advanced esophageal squamous-cell carcinoma ...




















